ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.00%
Dow Jones
39,872.99
0.00%
US Dollar vs MXN
16.65495
0.20%
Brent Oil
81.98
-0.56%
Bitcoin
69,763.38
-0.52%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Repligen Corp (RGEN)

  7. Repligen Corp (RGEN) Noticias

RGEN

Repligen (RGEN)

Repligen Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RGEN
FechaHoraFuenteTítuloSímboloCompañía
22/05/202406:30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming June Investor ConferencesNASDAQ:RGENRepligen Corp
21/05/202415:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
20/05/202418:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
17/05/202407:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
07/05/202406:30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming May Investor ConferencesNASDAQ:RGENRepligen Corp
01/05/202406:30GlobeNewswire Inc.Repligen Reports First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
17/04/202406:30GlobeNewswire Inc.Repligen to Report First Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
19/03/202406:30GlobeNewswire Inc.Repligen Appoints Maggie A. Pax to Board of DirectorsNASDAQ:RGENRepligen Corp
22/02/202415:26Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RGENRepligen Corp
21/02/202406:30GlobeNewswire Inc.Repligen Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RGENRepligen Corp
07/02/202406:30GlobeNewswire Inc.Repligen to Report Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RGENRepligen Corp
06/02/202412:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RGENRepligen Corp
19/12/202306:30GlobeNewswire Inc.Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RGENRepligen Corp
15/12/202318:04Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:RGENRepligen Corp
07/12/202306:30GlobeNewswire Inc.Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription AgreementsNASDAQ:RGENRepligen Corp
14/11/202313:01GlobeNewswire Inc.UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability ReportNASDAQ:RGENRepligen Corp
14/11/202306:30GlobeNewswire Inc.Repligen Announces Publication of the Company’s 2022 Sustainability ReportNASDAQ:RGENRepligen Corp
07/11/202306:30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming Investor ConferencesNASDAQ:RGENRepligen Corp
02/11/202306:30GlobeNewswire Inc.Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF DeviceNASDAQ:RGENRepligen Corp
31/10/202315:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGENRepligen Corp
31/10/202306:30GlobeNewswire Inc.Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceNASDAQ:RGENRepligen Corp
17/10/202306:30GlobeNewswire Inc.Repligen to Report Third Quarter 2023 Financial ResultsNASDAQ:RGENRepligen Corp
03/10/202319:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
02/10/202306:30GlobeNewswire Inc.Repligen Appoints Olivier Loeillot as President and Chief Commercial OfficerNASDAQ:RGENRepligen Corp
26/09/202306:30GlobeNewswire Inc.Repligen Announces Agreement to Acquire Fluid Management Innovator MetenovaNASDAQ:RGENRepligen Corp
12/09/202306:30GlobeNewswire Inc.Repligen Appoints Jason K. Garland as Chief Financial OfficerNASDAQ:RGENRepligen Corp
01/09/202306:30GlobeNewswire Inc.Repligen Corporation to Present at Wells Fargo Healthcare ConferenceNASDAQ:RGENRepligen Corp
17/08/202307:00GlobeNewswire Inc.Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process IntensificationNASDAQ:RGENRepligen Corp
02/08/202306:30GlobeNewswire Inc.Repligen Reports Second Quarter 2023 Financial Results and Updates Full Year 2023 Financial GuidanceNASDAQ:RGENRepligen Corp
19/07/202306:30GlobeNewswire Inc.Repligen to Report Second Quarter 2023 Financial ResultsNASDAQ:RGENRepligen Corp
 Showing the most relevant articles for your search:NASDAQ:RGEN

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
NYSE
AXP
American Express
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
CCOM
OILBRENT
Brent Oil
FX
USDMXN
US Dollar vs MXN
NASDAQ
QQQ
Invesco QQQ Trust Series 1
SPI
SP500
S&P 500
CCOM
US500
US 500
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
AMEX
SPY
SPDR S&P 500
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados